Veklury
- Product NDC
- 61958-2902
- 11-digit product format
- 619582902
- Labeler code
- 61958
- Product ID
- 61958-2902_da7319f5-e412-4afd-8456-369cb3a39a1f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- remdesivir
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Gilead Sciences, Inc.
- Application
- NDA214787
- Marketing category
- NDA
- Marketing start
- 2022-03-25
- Marketing end
- 0000-00-00
- Substance
- REMDESIVIR
- Active strength
- 5 mg/mL
- Pharmacologic classes
- SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61958-2902-2 | Veklury | 1 in 1 CARTON | INJECTION | 1 | | 23 |
| 61958-2902-2 | Veklury | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 20 | | 23 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61958-2902 | VEKLURY (REMDESIVIR) INJECTION VEKLURY (REMDESIVIR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GILEAD SCIENCES, INC.] | 20 | Legacy NDC, 2 package rows | 20250126_c0978fa8-53ff-4ca2-82a7-567fd3e958ca.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61958-2902-1 | 61958290201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61958-2902-1) > 20 mL in 1 VIAL, SINGLE-DOSE | 2020-05-01 | 2022-08-31 | No | No | Current |
| 61958-2902-2 | 61958290202 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61958-2902-2) > 20 mL in 1 VIAL, SINGLE-DOSE | 2021-09-01 | 0000-00-00 | No | No | Current |